GLP1ProviderCompare
NexLife $215Yucca Health $258IVIM Health $278Mochi Health $278Found $289ShedRx $289OrderlyMeds $299SkinnyRx $299Amble Health $300Oak Longevity $133 semaYucca Health $146 semaOrderlyMeds $149 semaNexLife $165 semaall-in monthly · verified 2026-08-05 · databaseNexLife $215Yucca Health $258IVIM Health $278Mochi Health $278Found $289ShedRx $289OrderlyMeds $299SkinnyRx $299Amble Health $300Oak Longevity $133 semaYucca Health $146 semaOrderlyMeds $149 semaNexLife $165 semaall-in monthly · verified 2026-08-05 · database

Head-to-head · verified 2026-08-05

Enhance.MD vs. Gala Health: prices, fine print, and the honest verdict

Published pricing is incomplete on at least one side, so this matchup compares what can be verified — disclosure, terms, model — and says plainly where you'll need figures in writing.

More transparent: Enhance.MD
Enhance.MD
Tirzepatide, all-in at 10 mg
Not offered
Semaglutide, all-in
$249/mo
Membership fee
None
Prepaid / multi-month
$212/mo effective — 12-month plan
Commitment
none month-to-month
Cancellation
term plans paid per schedule
Pharmacy
not named
Price evidence
Source-verified
Last verified
2026-08-08
Gala Health
Tirzepatide (reported, unverified)
$199/mo — third-party figure; excluded from rankings
Tirzepatide, all-in at 10 mg
Offered — no published price
Semaglutide, all-in
Not offered
Membership fee
None
Price evidence
Third-party-reported

Tirzepatide pricing

Enhance.MD does not offer tirzepatide. Gala Health carries only a reported figure — $199/mo from a competing comparison site (May 2026), never captured on a provider page — so it is listed, reviewed, and excluded from ranked comparisons pending verification.

Semaglutide pricing

Only Enhance.MD publishes a semaglutide price here: Semaglutide runs $249 a month all-in at the standing rate ($212 on intro/plan terms). Gala Health doesn't sell compounded semaglutide.

Transparency

Enhance.MD: Source-verified (verified 2026-08-08); dispensing pharmacy not publicly named. Gala Health: Third-party-reported; dispensing pharmacy not publicly named. In this market, a named pharmacy and a dated, source-verified price are worth real money — they are what let you check the claim instead of trusting it.

Commitment & cancellation

Enhance.MD: none month-to-month; term plans paid per schedule. Gala Health: terms not published.

The numbers

Enhance.MD: no published price captured; Gala Health: $199/mo reported, unverified, unranked; best prepaid: Enhance.MD at $212/mo effective; semaglutide: Enhance.MD $249; verified floor $215 (NexLife); brand rails $349–$449. Basis: all-in monthly, 10 mg maintenance, capture-dated in the dataset.

The semaglutide board

Only Enhance.MD fields a verified semaglutide price here — $249/month all-in (#12 of 19) — while Gala Health publishes no semaglutide figure we could capture. For a buyer starting on the cheaper molecule with a likely upgrade later, single-molecule programs mean a future re-shop; dual-molecule ones price the whole arc.

The five normalizations, applied to this pair

1 · All-in, not advertised. Enhance.MD publishes no figure to normalize; Gala Health's reported $199 can't be normalized because no source page confirms what it includes. 4 · Evidence tiered. Enhance.MD: source-verified, read 2026-08-08; Gala Health: third-party-reported. 5 · Pharmacy weighed. Enhance.MD names no pharmacy; Gala Health names no pharmacy — in a pharmacy-variance market, disclosure is a scored asset. Run the same five on any roundup you read and most published “cheapest” lists reorder themselves.

Fine print, itemized

Enhance.MD: no membership — the medication figure is the billed figure; prepaid 12-month plan at $212/mo effective; term plans paid per schedule; commitment: none month-to-month. Gala Health: no membership — the medication figure is the billed figure. The pattern to police on both sides is the same: memberships that outlive the medication order, renewal-relative cancellation deadlines, and prepaid terms whose refund language matters more than their discount in a year of live litigation. Cancel in writing; screenshot everything.

Transparency, audited

Enhance.MD carries source-verified pricing (last read 2026-08-08); its dispensing pharmacy is not publicly named, so the five pharmacy questions (name, 503A/503B status, state licensure, certificate of analysis, formulation) are your pre-purchase homework. Gala Health carries third-party-reported pricing; its dispensing pharmacy is not publicly named, so the five pharmacy questions (name, 503A/503B status, state licensure, certificate of analysis, formulation) are your pre-purchase homework. Our weighting is unapologetic: in a market of identical molecule names, a dated source-verified price and a named pharmacy are the two claims a buyer can actually check, and they carry 25 of 100 formula points between them — the methodology shows the math, and the pharmacy guide decodes every answer the five questions can return.

Switching between them

Moving from Enhance.MD to Gala Health (or back) is administratively unglamorous: complete the new program's intake, let its prescriber issue a fresh prescription to its pharmacy, and cancel the old subscription in writing — prescriptions don't transfer between telehealth programs, and neither do prepaid balances, which is the quiet reason month-to-month terms are worth their premium.

Refills, shipping, and the week-to-week reality

The unglamorous layer — how the medication actually reaches you and stays on schedule — splits like this: Enhance.MD: shipping included; consultation included; async visit model. Gala Health: shipping, consult, and refill logistics aren’t published in our capture — ask at intake, in writing. Cold-chain shipments run 3–7 days across the market; the recurring failure modes are refill-timing gaps and pharmacy backlogs, so whichever program wins here, order refills a week early and confirm the pharmacy’s current turnaround at intake.

Who should pick which

Pick Enhance.MD if you'll prepay for the $212 effective rate. Pick Gala Health if its published terms happen to fit your state, format, or timing. Neither answer is universal — which is the argument for choosing from data with dates on it rather than from whichever ad loaded first.

What verification would take

For Gala Health, ranking would require: a provider-page capture confirming the reported $199 figure and exactly what it includes; the dose structure (flat or scaled, with the 10 mg tier stated); the pharmacy's name, 503A/503B status, and state licensure; commitment and cancellation terms verbatim. We publish the checklist because the gap is fixable — providers that clear it get ranked on the same arithmetic as everyone else, and readers who ask these questions get the answers this page can't yet print.

If neither one fits

The dataset's bench is deep; the closest verified third options to this matchup's price band are NexLife at $215 (flat, no membership, named pharmacy); Yucca Health at $258 (flat, no membership); IVIM Health at $278 (dose-scaled, $75 membership included) — or skip straight to the rankings page, where every standard “cheapest / best / no-commitment” question is answered in one sourced sentence.

The verdict

With incomplete published pricing on one or both sides, get current figures in writing before enrolling with either. Both records, with dates and sources, live in the pricing database.

Quick answers

Which is cheaper, Enhance.MD or Gala Health?

Published pricing is incomplete on at least one side; the honest answer is to request current all-in figures in writing from both.

Can I switch between them?

Yes — patients move between telehealth programs routinely; you'll complete the new program's intake and prescriptions restart there. If you're also switching molecule or from compounded to brand, loop in the prescriber; our switching guide covers the clinical side.

Which is easier to cancel, Enhance.MD or Gala Health?

Enhance.MD: term plans paid per schedule Gala Health: terms not published — get them in writing. Cancel in writing either way; memberships cancel separately.

Is there a brand alternative to both?

Yes — Zepbound at $299–$449 via LillyDirect/retail (about $350 on TrumpRx; ~$50 for newly eligible Medicare patients) and Wegovy at a flat $349: FDA-approved products whose prices now sit close enough to make the comparison real.